Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). [electronic resource]
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases Jul 2020
- 880-894 p. digital
Publication Type: Journal Article; Review
1469-0691
10.1016/j.cmi.2020.04.031 doi
Anti-Inflammatory Agents--therapeutic use Antiviral Agents--therapeutic use Betacoronavirus--drug effects COVID-19 Coronavirus Infections--drug therapy Humans Intensive Care Units--statistics & numerical data Italy--epidemiology Lung Diseases--drug therapy Off-Label Use--ethics Pandemics Pneumonia, Viral--drug therapy Respiration, Artificial--methods SARS-CoV-2